We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

96 hedge funds and large institutions have $136M invested in Cytosorbents Corp in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 19 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 19

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

22% more capital invested

Capital invested by funds: $111M → $136M (+$24.8M)

8.72% more ownership

Funds ownership: 31.12% → 39.84% (+8.7%)

5% more funds holding

Funds holding: 91 → 96 (+5)

22% less call options, than puts

Call options by funds: $593K | Put options by funds: $760K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
96
Holders Change
+5
Holders Change %
+5.49%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
36
Reduced
19
Closed
14
Calls
$593K
Puts
$760K
Net Calls
-$167K
Net Calls Change
-$1.4M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$19M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$14.7M
3
Neuberger Berman Group
Neuberger Berman Group
New York
+$5.26M
4
BlackRock
BlackRock
New York
+$3.68M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.74M

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$1.63M
2
EGI
EAM Global Investors
California
-$1.13M
3
Squarepoint
Squarepoint
New York
-$840K
4
Victory Capital Management
Victory Capital Management
Texas
-$729K
5
Deutsche Bank
Deutsche Bank
Germany
-$412K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$25K -$30K -3,320 -51%
AIP
77
Ameritas Investment Partners
Nebraska
$21K – – –
Federated Hermes
78
Federated Hermes
Pennsylvania
$21K +$9.98K +1,106 +73%
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
$19K -$7.67K -850 -26%
GT
80
Glenmede Trust
Pennsylvania
$17K +$614 +68 +3%
Citigroup
81
Citigroup
New York
$16K -$24.4K -2,709 -58%
IA
82
IFP Advisors
Florida
$16K +$17.7K +1,967 New
PCM
83
Prelude Capital Management
New York
$16K +$18K +2,000 New
SFS
84
Sowell Financial Services
Arkansas
$13K – – –
APA
85
American Portfolios Advisors
New York
$11.2K – – –
AF
86
Advisornet Financial
Minnesota
$9K – – –
AA
87
Ancora Advisors
Ohio
$6K – – –
AWM
88
Adams Wealth Management
Utah
$3K +$3.61K +400 New
UBS Group
89
UBS Group
Switzerland
$2K -$119K -13,176 -98%
S
90
SignatureFD
Georgia
$2K -$2.06K -228 -50%
PA
91
Parallel Advisors
California
$2K – – –
HFRG
92
Houlihan Financial Resource Group
Virginia
$2K +$2.71K +300 New
Millennium Management
93
Millennium Management
New York
$1.04K +$1.18M +130,937 New
LC
94
Lindbrook Capital
California
$1K – – –
PFWA
95
Paces Ferry Wealth Advisors
Georgia
$1K +$695 +77 New
EI
96
EAM Investors
California
– -$1.63M -164,400 Closed
EGI
97
EAM Global Investors
California
– -$1.13M -114,109 Closed
Squarepoint
98
Squarepoint
New York
– -$840K -84,823 Closed
Victory Capital Management
99
Victory Capital Management
Texas
– -$729K -73,630 Closed
CPA
100
Cowen Prime Advisors
New York
– -$92K -42,200 Closed
1 2 3
4
5

CTSO Hedge Fund Activity: Q3 2020 in Review

96 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2020, worth a combined $136M — up 22% from $111M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CTSO positions and 14 closed out — a net gain of 6 holders — while 36 added to existing stakes and 19 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $19M. The largest seller was EAM Investors, exiting entirely with an estimated $1.63M sold.

  • 96 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2020, up from 91 in Q2 2020.
  • Funds reported $136M of Cytosorbents Corp stock for Q3 2020, up 22% quarter-over-quarter.
  • 20 funds opened new Cytosorbents Corp positions in Q3 2020 and 14 closed out, a net change of +6 holders.
  • The largest Cytosorbents Corp buyer in Q3 2020 was Redmile Group, an estimated $19M added.
  • The largest Cytosorbents Corp seller in Q3 2020 was EAM Investors, an estimated $1.63M sold.

Based on aggregated 13F filings for Q3 2020.